The Semaglutide Treatment Effect in People with Obesity (STEP) trials showed 12%-15% weight loss with semaglutide, less in type 2 diabetes patients
doi: 10.1016/j.clinthera.2021.11.007
Esto no es de extraar, ya que el paciente con DM2 tiene una mayor predisposicin a rotura, trombosis y cicatrizacin, lo que produce ms crecimiento y vulnerabilidad de la placa de ateroma
Individuals with upregulated CYP450 2E1, such as alcoholics, are particularly vulnerable to liver failure from APAP use [7, 8]
Many patients find the act of manual entry increases awareness and engagement
Taki sposb dziaania umoliwia lepsz kontrol nad rezultatami, a jednoczenie minimalizuje ryzyko wystpienia niepodanych efektw